Acute Market Reports, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Vietnam. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.
Browse Full Report Visit - http://www.acutemarketreports.com/report/countryfocus-healthcare-regulatory-and-reimbursement-landscape-vietnam
In 2013, Vietnams population stood at 89.7 million, an increase from 85.1 million in 2008 due to the high birth rate and low mortality rate. The countrys pharmaceutical market was estimated to have been worth $2.9 billion in 2013 and is expected to reach $8 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 15.4%. According to an EU Economic and Commercial Counsellor (EUECC) report in 2011, Vietnams medical device market was estimated at approximately $220m in 2010 and is expected to grow at a CAGR of 10% to over $350m by 2015.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/pharmaceutical-market
- The positive trends in Vietnams healthcare market can primarily be attributed to
- Increasing coverage of healthcare insurance
- Government initiatives to improve healthcare facilities
Scope
- This report provides information on the healthcare, regulatory, and reimbursement landscape in the Vietnam, including the following
- Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, GlaxoSmithKline, AstraZeneca, Novartis and DHG Pharmaceutical JSC
- An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
- The report will enhance your decision-making capability by allowing you to
- Develop business strategies through an understanding of the trends shaping and driving the healthcare market
- Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market
- 1 Table of Contents7
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 17
2.1 GlobalData Report Guidance 17
3 Overview of the Pharmaceutical and Medical Device Markets 18
3.1 Pharmaceutical Market 18
3.1.1 Market Overview 18
3.1.2 Pharmaceutical Imports and Exports 22
3.1.3 Supply Channels 23
3.1.4 Market Segments 24
3.1.5 Overview of Major Disease Areas 29
3.1.6 Major Players 34
3.2 Medical Device Market 70
3.3 Market Drivers and Barriers 71
3.3.1 Drivers 71
3.3.2 Barriers 73
4 Market Access 75
4.1 Reimbursement and Payer Landscape 75
4.1.1 Overview of Healthcare System 75
4.1.2 Reimbursement Process 76
4.1.3 Overview of Insurance Providers 78
4.1.4 Patient Share in Healthcare Spending 83
4.1.5 Drug Price Trend 84
4.1.6 Pricing Policies 85
4.2 Regulatory Landscape 86
4.2.1 Overview of Regulatory Agencies 86
4.2.2 Market Authorization Procedure for Pharmaceutical Products 86
4.2.3 Licensing Process for Pharmaceutical Manufacturing 93
4.2.4 Licensing Process for Pharmaceutical Exports and Imports 94
4.2.5 Intellectual Property Rights 96
4.2.6 Clinical Trial Regulations 100
4.2.7 Pharmaceutical Advertising Regulations 102
4.2.8 Pharmacy Regulations 104
4.2.9 Labeling and Packaging Regulations 105
Our Blogs :-
http://www.qyresearchreports.net/
http://www.deepresearchreport.com/
http://www.profresearchreport.com/
http://www.deepresearchreport.com/
http://www.profresearchreport.com/
For Technology News : http://www.mobilecomputingtoday.co.uk
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
No comments:
Post a Comment